Picture of United Laboratories International Holdings logo

3933 — United Laboratories International Holdings News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: United Laboratories International Says Unit Received Approval Of Clinical Trial By NMPA

April 14 (Reuters) - United Laboratories International
Holdings Ltd  3933.HK :
    * UNIT RECEIVED NOTICE OF APPROVAL OF CLINICAL TRIAL BY NMPA
FOR
INSULIN DEGLUDEC AND LIRAGLUTIDE INJECTION


Further company coverage:  3933.HK 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on United Laboratories International Holdings

See all news